Navigation Links
Aeolus Pharmaceuticals' AEOL 10150 Highlighted in Nature Genetics,Publication

LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Apr 18, 2007 - Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) announced today that a new report published in the medical journal, Nature Genetics (Tong et al. Nature Genetics 39:476-485, 2007), showed that Aeolus Pharmaceuticals' lead compound AEOL 10150 (MnTDEIP) can improve survival in fruit flies genetically lacking the neurofibromatosis-1 (NF1) gene. These mutant flies had reduced mitochondrial function and increased production of reactive oxygen species that was associated with a greatly shortened lifespan. Dr. Douglas Wallace's team at the University of California-Irvine concluded that the increased mitochondrial Reactive Oxygen Species (ROS) production resulting from NF1 mutations could be an important factor in the generation of neurofibromas. If so, then the suppression of mitochondrial ROS production through the treatment with catalytic antioxidants such as AEOL 10150 may provide a powerful new approach to treat NF1, as well as other cancers.

Many common neurodegenerative diseases including Parkinson's disease, Amyotrophic lateral sclerosis (ALS), and Alzheimer's disease are often associated with mitochondrial dysfunction and the overproduction of reactive oxygen species. Neurofibromatosis is a common neurogenetic disorder that afflicts 1 in 3,000 people worldwide. Humans that harbor mutant neurofibromatous-1 genes are at increased risk of developing cancer and often have learning disabilities and developmental abnormalities.

AEOL 10150 has been shown to be safe and well-tolerated in both a single and a multi-dose phase 1 studies. In animal models, the compound has shown promise in ALS, protection of healthy cells from radiation therapy, Parkinson's disease, stroke and neurofibromatosis, among other indications. The Company is currently in the process of planning and securing the financial resources to support a phase 2 study to test the efficacy of AEOL 10150
'"/>




Page: 1 2 3

Related medicine technology :

1. Study Demonstrating Aeolus Compounds Neuroprotection in Parkinsons Disease Published in the Journal of Neuroscience
2. Aeolus Pharmaceuticals AEOL 10113 May Play an Important Role Regulating the Oxidative Damage Induced by Ionizing Radiation
3. Aeolus Pharmaceuticals AEOL 10113 Demonstrates Potential as a Protector of Healthy Normal Cells from Cancer Radiation Therapy
4. Aeolus Pharmaceuticals Announces Successful Completion of Multiple Dose Safety Study of AEOL 10150
5. Faust Pharmaceuticals Phase IIa Results for Parkinsons Disease Presented at International Congress of Parkinsons Disease and Movement Disorders
6. Data from Rexahn Pharmaceuticals Phase I Trial of RX-0201 (Archexin) to Be Presented at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago
7. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
8. ACADIA Pharmaceuticals Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
9. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
10. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
11. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
Post Your Comments:
(Date:3/2/2015)... 2, 2015  Champions Oncology, Inc. (OTC-PINK: CSBR), a ... and services to personalize the development and use of ... the $2 million convertible promissory notes with two of ... Dr. David Sidransky , chairman of ... from the confidence and commitment of our two senior ...
(Date:3/2/2015)... HOUSTON, TX , March 2, 2015 ... (TSX-V: EPI) today reported financial results for the first ... unless specified otherwise, are expressed in Canadian dollars and ... Summary Results ESSA recorded ... share) for the three months ended December 31, 2014 ...
(Date:3/2/2015)... , March 2, 2015 Attorney Advertising ... potential claims on behalf of purchasers of the ... the "Company") (NasdaqGM: VTAE -News).  Such investors are ... his investor relations coordinator Eitan Kimelman ... The investigation concerns whether Vitae Pharmaceuticals and certain ...
Breaking Medicine Technology:Champions Oncology Extends Convertible Debt Financing 2Champions Oncology Extends Convertible Debt Financing 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 4SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2
(Date:3/2/2015)... March 02, 2015 GBCHealth, a ... catalyzing private sector activities and investments in global ... elected four new members to serve on the ... Paul Farmer, Chief Strategist and Co-founder of Partners ... University; Dr. Huma Abbasi, General Manager of Global ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... Buffett tickets at the Hollywood Bowl . This popular ... add customer appreciation promo code JIMMY-BUFFETT-2015 for added savings. ... because their favorite performer will be headlining at the ... This concert will be on Thursday, October 22nd and ...
(Date:3/2/2015)... March 02, 2015 While many hospitals ... VI of the Civil Rights Act, the unique needs ... loss are bringing light to the value of video ... that nearly 1 in 20 U.S. children have LEP—a ... in some major cities.(1) Stratus Video Interpreting ...
(Date:3/2/2015)... 2015 ZoomCare announced today the ... healthcare. Zoom will expand its Portland on-demand neighborhood ... advanced care studios delivering urgent care, primary care, ... care and outpatient surgery. With its new neighborhood ... all healthcare needs outside of hospitalization. , “2015 ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3
... epinephrine causes changes in prostate and breast cancer cells that ... study. // ,"This data implies that emotional stress ... reduce the effectiveness of cancer treatments," said George Kulik, a ... ,Levels of epinephrine, which is produced by the adrenal ...
... with findings that dispel the halo around dieting regimes. Not ... they also stand higher risks of developing diabetes, heart attacks ... in the journal American Psychologist, based their research on thousands ... more than 30 studies on the subject. , ...
... Health Organization has reiterated the earlier warning about the ... consumption salt. The report has impressed upon governments world-wide ... sodium to 2,000 milligrams per day, 50% less than ... has been pressurizing the U.S. Food and Drug Administration ...
... to be flooding their body with dietary supplements, without ... $5.8 billion //is spent by Americans annually on dietary ... diseases at bay and extend life. ... claims of enhancing cardiovascular health. Ginkgo biloba, another dietary ...
... to 301 in 2006, the maternal mortality ratio (MMR) that ... falling in India, albeit gradually. ,As India observes ... MMR rate, the number of mothers dying per 100,000 live ... of the White Ribbon Alliance (WRA), an international body that ...
... with Parkinson's disease are less likely to smoke ... family members who do not have the disease//, ... consuming caffeine and taking non-steroidal anti-inflammatory (NSAID) medications ... reported to protect individuals from developing Parkinson's disease, ...
Cached Medicine News:Health News:Dieting Fads -Flab Revisited 2Health News:Ray of Hope for Women on Motherhood Day 2Health News:Smoking and Caffeine Inversely Associated With Parkinson's Disease 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: